Text this: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

   _____    _____    _    _    _    _             
  / ___//  |  ___|| | || | || | || | ||     ___   
  \___ \\  | ||__   | || | || | || | ||    /   || 
  /    //  | ||__   | \\_/ || | \\_/ ||   | [] || 
 /____//   |_____||  \____//   \____//     \__ || 
`-----`    `-----`    `---`     `---`       -|_|| 
                                             `-`